Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EPAM Systems, Inc. (“EPAM” or “the Company”) (NYSE: EPAM). Investors who purchased EPAM securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether EPAM has violated federal securities laws.

EPAM Investigation Details

On February 19, 2026, EPAM reported its financial results for fourth quarter and full year 2025. On an earnings call that same day, EPAM’s Chief Financial Officer acknowledged a decline in revenue from the largest customer of EPAM’s NEORIS business, indicating that the “customer was going to ramp down business between Q4 and Q1.” Following this news, EPAM’s stock price dropped $9.20 per share, or 6.61%, over the following two trading sessions, to close at $129.96 on February 23, 2026.

What’s Next for EPAM Investors?

If you are aware of any facts relating to this investigation or purchased EPAM securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911